Recro Pharma Inc.

Recro Pharma Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.28
Market Cap
$233.34 M
Shares Outstanding
22.18 M
Public Float
17.54 M

Profile

Address
490 Lapp Road
Malvern Pennsylvania 19355
United States
Employees -
Website http://www.recropharma.com
Updated 07/08/2019
Recro Pharma, Inc. is a pharmaceutical company, which engages in the research and development of non-opioid therapeutics for the treatment of acute post operative pain. It operates through the Acute Care, and Contract Development and Manufacturing (CDMO) business segment. The Acute Care segment focuses on developing innovative products for hospital and related settings.

Financials

View All

Gerri A. Henwood
President, Chief Executive Officer & Director
Wayne B. Weisman
Chairman